ArticleScientific reports2022

Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer.

Yuji Hakozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.